Spots Global Cancer Trial Database for mln4924
Every month we try and update this database with for mln4924 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors | NCT01862328 | Solid Tumors | MLN4924 Paclitaxel Gemcitabine Docetaxel Carboplatin | 18 Years - | Takeda | |
| Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma | NCT00722488 | Hematologic Mal... Multiple Myelom... Lymphoma Hodgkin Lymphom... | MLN4924 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Dose Escalation Study of MLN4924 in Adults With Melanoma | NCT01011530 | Metastatic Mela... | MLN4924 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Dose Escalation Study of MLN4924 in Adults With Melanoma | NCT01011530 | Metastatic Mela... | MLN4924 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Study of MLN4924 in Adult Patients With Nonhematologic Malignancies | NCT00677170 | Advanced Nonhem... | MLN4924 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older | NCT01814826 | Acute Myelogeno... | MLN4924 Azacitidine | 60 Years - | Takeda | |
| Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | NCT02122770 | Advanced Solid ... | MLN4924 Fluconazole Itraconazole Docetaxel Carboplatin Paclitaxel | 18 Years - | Takeda | |
| Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | NCT02122770 | Advanced Solid ... | MLN4924 Fluconazole Itraconazole Docetaxel Carboplatin Paclitaxel | 18 Years - | Takeda | |
| Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors | NCT01862328 | Solid Tumors | MLN4924 Paclitaxel Gemcitabine Docetaxel Carboplatin | 18 Years - | Takeda | |
| MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia | NCT00911066 | Acute Myelogeno... Acute Lymphobla... Myelodysplastic... | MLN4924 Azacitidine | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | NCT02122770 | Advanced Solid ... | MLN4924 Fluconazole Itraconazole Docetaxel Carboplatin Paclitaxel | 18 Years - | Takeda | |
| MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma | NCT01415765 | Lymphoma, Diffu... Diffuse, Large ... Lymphoma, Diffu... Large-Cell Lymp... | MLN4924 Etoposide Prednisone Vincristine Cyclophosphamid... Doxorubicin Rituximab Filgrastim | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Dose Escalation Study of MLN4924 in Adults With Melanoma | NCT01011530 | Metastatic Mela... | MLN4924 | 18 Years - | Millennium Pharmaceuticals, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
